Intratumoral Genetic Heterogeneity in Papillary Thyroid Cancer: Occurrence and Clinical Significance
Open Access
Abstract
Intratumoral heterogeneity (ITH) refers to a subclonal genetic diversity observed within a tumor. ITH is the consequence of genetic instability and accumulation of genetic alterations, two mechanisms involved in the progression from an early tumor stage to a more aggressive cancer. While this process is widely accepted, the ITH of early stage papillary thyroid carcinoma (PTC) is debated. By different genetic analysis, several authors reported the frequent occurrence of PTCs composed of both tumor cells with and without RET/PTC or BRAFV600E genetic alterations. While these data, and the report of discrepancies in the genetic pattern between metastases and the primary tumor, demonstrate the existence of ITH in PTC, its extension and biological significance is debated. The ITH takes on a great significance when involves oncogenes, such as RET rearrangements and BRAFV600E as it calls into question their role of driver genes. ITH is also predicted to play a major clinical role as it could have a significant impact on prognosis and on the response to targeted therapy. In this review, we analyzed several data indicating that ITH is not a marginal event, occurring in PTC at any step of development, and suggesting the existence of unknown genetic or epigenetic alterations that still need to be identified.Keywords
Funding Information
- Ricerca Finalizzata, Italian Ministry of Health (RF 2013-02354985)
- Ministero dell'Istruzione, dell'Università e della Ricerca (PRIN 2017YTWKWH)
This publication has 81 references indexed in Scilit:
- Concomitant
BRAF
V600E
Mutation and RET/PTC Rearrangement Is a Frequent Occurrence in Papillary Thyroid CarcinomaThyroid®, 2014
- Genetic heterogeneity and cancer drug resistanceThe Lancet Oncology, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell levelBritish Journal of Cancer, 2012
- Thyroid cancer stem cellsNature Reviews Endocrinology, 2011
- Polyclonality of BRAF mutations in primary melanoma and the selection of mutant alleles during progressionBritish Journal of Cancer, 2011
- Chromosomal Rearrangements in Post‐Chernobyl Papillary Thyroid Carcinomas: Evaluation by Spectral Karyotyping and Automated Interphase FISHBioMed Research International, 2011
- Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles forBRAF, PIK3CA, andAKT1Cancer Research, 2009
- High Rate of BRAF and RET/PTC Dual Mutations Associated with Recurrent Papillary Thyroid CarcinomaClinical Cancer Research, 2009
- RET rearrangements in post-Chernobyl papillary thyroid carcinomas with a short latency analysed by interphase FISHBritish Journal of Cancer, 2006